Clinical Trials Logo

Filter by:
NCT ID: NCT06376877 Not yet recruiting - Anxiety Disorders Clinical Trials

Connectomic Targeted TMS Target for Refractory Anxiety

ConTRA
Start date: August 1, 2024
Phase: Phase 2
Study type: Interventional

We will perform a randomized sham-controlled trial of aiTBS to an anxiosomatic circuit in patients with anxiety-related disorders (i.e., panic disorder, generalized anxiety disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder). 80 participants with an anxiety-related disorder (defined below) will receive 50 active or sham TMS treatments over 5 days (following the SAINT protocol, which is FDA-cleared for MDD. The primary outcome will be the BAI, with a modified recall window to reflect the short treatment interval. Participants randomized to sham will be offered an open-label crossover extension.

NCT ID: NCT06377540 Not yet recruiting - Clinical trials for Classic Hodgkin Lymphoma

MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma

Start date: August 1, 2024
Phase: Phase 2
Study type: Interventional

This is a Phase 2 single arm study to evaluate efficacy and safety of Pembrolizumab before with BEAM ASCT followed by Pembrolizumab maintenance for 1 year. Patients will receive 200 mg Pembrolizumab Q3week starting at day - 28 before stem cell transplant until 1 year after autologous stem cell transplant.

NCT ID: NCT06379711 Not yet recruiting - Clinical trials for Cardiovascular Diseases

Cardiopulmonary Changes Following Spinal Cord Stimulation in Individuals With Spinal Cord Injury

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to examine the mechanisms of transcutaneous spinal cord stimulation (tSCS) for improving cardiovascular and pulmonary function in individuals with chronic motor-complete spinal cord injury (SCI) by measuring vascular related endothelial biomarkers, plasma catecholamines, and respiratory parameters.

NCT ID: NCT06384300 Not yet recruiting - Gastric Cancer Clinical Trials

Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Gastric cancer, also known as stomach cancer, is a serious disease that affects the stomach. It's one of the most common types of cancer, and sadly, many people die from it each year. But there's hope! We can catch gastric cancer early with a special test called endoscopy. This test helps doctors find cancer or pre-cancerous changes in the stomach early, when it's easier to treat. However, not enough people get this test, especially in places where healthcare isn't easily available. That's why we're doing this study. We want to find out if we can encourage more people to get the endoscopy test for gastric cancer. We're going to try two different ways to encourage people to get the test. First, we'll give some people money or other incentives to help cover the costs of getting the test. Second, we'll give others information and support to help them understand why the test is important and how it can help them. We'll be doing this study in two provinces in China, where gastric cancer is a big problem. We'll ask thousands of people to join the study, and we'll randomly assign them to one of the two groups. Then, we'll see if more people in one group get the endoscopy test compared to the other group. Our hope is that by finding out what works best, we can help more people catch gastric cancer early and get the treatment they need. This could save many lives and make a big difference in fighting this disease.

NCT ID: NCT06387355 Not yet recruiting - Clinical trials for Coronary Artery Disease

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

CAD in sPAD
Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Peripheral artery disease, lack or blood flow to the legs, has a high prevalence in the Veteran population. In patients with severe peripheral artery disease that requires an endovascular or surgical intervention for lower leg revascularization, the long-term mortality of approximately 50% is worse that most cancers. The goal of this study is to develop a management strategy to improve cardiovascular outcomes in this high-risk peripheral artery disease population after lower extremity revascularization.

NCT ID: NCT06388057 Not yet recruiting - Crohn Disease Clinical Trials

Intraoperative Ultrasound in Crohn's Disease

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

To study the role of intraoperative ultrasound of small bowel as a possible tool that can reduce the rate of histologically involved resection margins from Crohn's Disease.

NCT ID: NCT06388421 Not yet recruiting - Clinical trials for Pulmonary Hypertension

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Start date: August 1, 2024
Phase:
Study type: Observational

This is a prospective, non-interventional, multicenter, registry of patients with pulmonary associated with interstitial lung disease (PH-ILD).

NCT ID: NCT06388707 Not yet recruiting - Epilepsy Clinical Trials

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

Start date: August 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).

NCT ID: NCT06396078 Not yet recruiting - Preterm Birth Clinical Trials

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Start date: August 1, 2024
Phase: Phase 4
Study type: Interventional

To conduct an unblinded pragmatic randomized controlled trial (pRCT) "Improvement of PPROM Management with Prophylactic Antimicrobial Therapy (iPROMPT)" of a seven-day course of ceftriaxone, clarithromycin, and metronidazole versus the current standard of care of a seven-day course of ampicillin/amoxicillin and azithromycin or erythromycin to prolong pregnancy and decrease adverse perinatal outcomes among hospitalized pregnant individuals undergoing expectant management of PPROM <34 weeks.

NCT ID: NCT06396195 Not yet recruiting - Caries,Dental Clinical Trials

Comparative Evaluation of Bioflx Crowns vs Stainless Steel Crowns

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Comparative Evaluation of Clinical Success,Parental and child Satisfaction of Bioflx Crowns Versus Stainless Steel Crowns as Restorations for Primary Molars: A Randomized Clinical Study